External validation of an artificial neural network and two nomograms for prostate cancer detection.

about

Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.

P2860

Q38268839-56062446-9FE5-4995-9A77-6F5ECCA16278

P2860

External validation of an artificial neural network and two nomograms for prostate cancer detection.

Item

http://www.wikidata.org/entity/Q41832537

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

External validation of an arti ...... for prostate cancer detection.

@en

type

Item

label

External validation of an arti ...... for prostate cancer detection.

@en

prefLabel

External validation of an arti ...... for prostate cancer detection.

@en

P1476

External validation of an arti ...... for prostate cancer detection.

@en

P2093

Carsten Stephan

http://www.w3.org/2001/XMLSchema#string

Henning Cammann

http://www.w3.org/2001/XMLSchema#string

Holger Gerullis

http://www.w3.org/2001/XMLSchema#string

Jürgen Ruttloff

http://www.w3.org/2001/XMLSchema#string

Kurt Miller

http://www.w3.org/2001/XMLSchema#string

Stefan Koch

http://www.w3.org/2001/XMLSchema#string

Steffen Hallmann

http://www.w3.org/2001/XMLSchema#string

Thorsten H Ecke

http://www.w3.org/2001/XMLSchema#string

P2860

The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.

External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets.

Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

The problem of cutoff levels in a screened population: appropriateness of informing screenees about their risk of having prostate carcinoma.

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

P304

643181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5402/2012/643181

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230566306

http://www.w3.org/2001/XMLSchema#string

P698

22830050

http://www.w3.org/2001/XMLSchema#string

P932

3399415

http://www.w3.org/2001/XMLSchema#string

External validation of an artificial neural network and two nomograms for prostate cancer detection.

about

P2860

P2860

External validation of an artificial neural network and two nomograms for prostate cancer detection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932